Download PDF

Other users also viewed these articles

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;
Nefrologia (English Version). 2022;42:390-403
Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;
Nefrologia (English Version). 2021;41:258-75
Cardiorenal unit in advanced cardiorenal disease: Clinical impact and reduction of hospital costs Eliecer Soriano Payá; Ismael Arco Adamuz; Ana María García Girón; Francisco José Bermúdez Jiménez; Elisa Berta Pereira Pérez; Laura Jordán Martínez; María Carmen Olvera-Porcel; Leticia García Mochón; Silvia López Fernández; María José Espigares Huete;
10.1016/j.nefroe.2025.501350